X-ray-endovascular interventions in the treatment of patients with liver metastases of colorectal cancer after the termination of systemic chemotherapy
Open Access
- 3 July 2022
- journal article
- research article
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 13 (2) , 59-65
Abstract
Background: At present, the problem of treating common forms of colorectal cancer does not lose its relevance due to the increase in its incidence. Systemic chemotherapy is the main line of treatment for patients with unresectable liver metastases. However, a significant problem of modern oncology is the further treatment tactics for patients with chemoresistant metastases. Aims: to improve the treatment results for patients with chemoresistant liver metastases of colorectal cancer. Method: 36 patients with unresectable liver metastases of colorectal cancer were treated at the Granov Russian Research Center of Radiology and Surgical Technologies and the RZD-Medicine Central Clinical Hospital. For all the patients, systemic chemotherapy was considered unreasonable due to the development of chemoresistance or a high degree of toxicity. The patients underwent regional chemotherapy chemoinfusion and/or chemoembolization of the hepatic artery. Results: The treatment evaluation was performed using the RECIST 1.1 scale. After 6 months, a partial response was reached in 1 patient (2.8%), stabilization was observed in 29 (80.5%) patients, and 6 patients (16.7%) had the disease progression. In 2 (5.6%) cases, a lethal outcome was observed against the background of the systemic progression of the oncological disease. One year later, stabilization of the malignant process was detected in 21 (58.3%) cases, progression was detected in 15 (41.7%) cases. A one-year survival of patients was 83.3%, the overall survival 22 months. Conclusion: The use of interventional radiology methods has shown its effectiveness in patients with unresectable chemoresistant liver metastases of colorectal cancer.Keywords
This publication has 9 references indexed in Scilit:
- Cancers Metastatic to the LiverSurgical Clinics of North America, 2020
- Transarterial chemoembolization of unresectable systemic chemotherapy refractory liver metastases: a retrospective single-center analysisAbdominal Radiology, 2020
- Intraarterial chemotherapy in treatment of unresectable colorectal liver metastases refractory to systemic chemotherapyAnnaly khirurgicheskoy gepatologii = Annals of HPB surgery, 2019
- Cancer statistics, 2018CA: A Cancer Journal for Clinicians, 2018
- TREATMENT OUTCOMES OF COLORECTAL CANCER WITH BILATERAL LIVER METASTASESSiberian journal of oncology, 2017
- Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use programBMC Cancer, 2016
- Minimally invasive methods of local treatment for colorectal cancer liver metastases: state-of-the art (a review of literature)Surgery and Oncology, 2016
- Efficacy and Toxicity of Hepatic Intra‐Arterial Drug‐Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan‐Refractory Unresectable Colorectal Liver MetastasesWorld Journal of Surgery, 2015
- Transarterial chemoembolization of unresectable systemic chemotherapy‐refractory liver metastases from colorectal cancer: Long‐term results over a 10‐year periodInternational Journal of Cancer, 2013